OXABOLONE CIPIONATE

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C26H38O4
Molecular Weight	414.5775
Optical Activity	UNSPECIFIED
Defined Stereocenters	6 / 6
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[H][C@@]12CC[C@H](OC(=O)CCC3CCCC3)[C@@]1(C)CC[C@]4([H])[C@@]5([H])CCC(=O)C(O)=C5CC[C@@]24[H]

InChI

InChIKey=KHKDIUPVDIEHAH-KXLSUQFWSA-N

InChI=1S/C26H38O4/c1-26-15-14-18-17-9-11-22(27)25(29)20(17)8-7-19(18)21(26)10-12-23(26)30-24(28)13-6-16-4-2-3-5-16/h16-19,21,23,29H,2-15H2,1H3/t17-,18-,19-,21+,23+,26+/m1/s1

HIDE SMILES / InChI

Molecular Formula	C26H38O4
Molecular Weight	414.5775
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	6 / 6
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: https://books.google.ru/books?id=afKLA-6wW0oC&pg=PT525&lpg=PT525&dq=steranabol+osteoporosis&source=bl&ots=Me0fhNo13O&sig=wgFxsnNUDN9oJgG1lVXng8vozZc&hl=en&sa=X&ved=0ahUKEwjRx9He-_fOAhVFCywKHV6CBXwQ6AEILTAD#v=onepage&q=steranabol%20osteoporosis&f=false Retrieved from Anabolics By William Llewellyn
Curator's Comment: Description was created based on several sources, including http://pilarmartinescudero.es/EneroFebreroMarzo2014/capillary_investigation_oxabolone_man.pdf and http://www.basskilleronline.com/profile-steranabol.shtml

Oxabolone is a synthetic anabolic steroid. It can be formulated as the cipionate ester prodrug oxabolone cipionate. Oxabolone cypionate is a structural derivative of nandrolone. It differs via the additional 4-hydroxyl group that is attached, therefore making oxabolone cypionate 4-hydroxynandrolone. Oxabolone is on the World Anti-Doping Agency's list of prohibited substances, and is therefore banned from use in most major sports. Oxabolone cypionate is a relatively rare drug that was once produced in Europe for human use. Was used for the treatment of osteoporosis. It is no longer produced by pharmaceutical companies; Upjohn and Pharmacia were the primary producers of it previously.

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Androgen Receptor 167 Target ID: CHEMBL1871 Sources: http://www.kegg.jp/entry/D01149	Agonist 2678

Conditions

Condition	Modality	Targets	Highest Phase	Product
Chronic hepatitis 9 Sources: http://www.ncbi.nlm.nih.gov/pubmed/1164878	Palliative		Preclinical	Unknown Approved Use Unknown
Osteoporosis 97 Sources: http://www.ndrugs.com/?s=steranabol	Primary		Withdrawn	Steranabol Approved Use Indications: anabolic, osteoporosis, diabetic retinopathy

PubMed

Title	Date	PubMed
Mucosal hyperpigmentation due to oxabolone.	1995 Mar	7604652

Patents

Sample Use Guides

In Vivo Use Guide

The recommended dosage is 100-300 mg/week for about 6-12 weeks

Route of Administration: Intramuscular

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:03:01 GMT 2023` Edited by `admin` on `Fri Dec 15 16:03:01 GMT 2023`
Record UNII	5RXY50Q01N
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

OXABOLONE CIPIONATE

Official Name

English

NSC-522767

Code

English

4,17.BETA.-DIHYDROXYESTR-4-EN-3-ONE 17-CYCLOPENTANEPROPIONATE

Systematic Name

English

OXABOLONE 17-CYCLOPENTANEPROPIONATE [MI]

Common Name

English

FI-5852

Code

English

oxabolone cipionate [INN]

Common Name

English

OXABOLONE CIPIONATE [JAN]

Common Name

English

OXABOLONE CIPIONATE [MART.]

Common Name

English

Oxabolone cipionate [WHO-DD]

Common Name

English

FI 5852

Code

English

Classification Tree Code System Code

WHO-VATC

QA14AB03